FAQ: BioMed X and Novo Nordisk Collaboration on Oral Peptide Drug Delivery

What is the main goal of the collaboration between BioMed X and Novo Nordisk?

The main goal is to develop novel oral formulation technologies that achieve site-specific, prolonged retention of tablets or capsules within the lower small intestine to improve the absorption and bioavailability of peptide-based therapeutics.

Why is this collaboration significant?

This collaboration addresses a critical challenge in drug development by aiming to make peptide drugs orally available, which could significantly impact patients’ lives by improving treatment compliance and effectiveness.

How will the research team approach the challenge of oral peptide drug delivery?

The research team will work on developing technologies for prolonged retention of oral peptide formulations in the gut, focusing on the lower small intestine for continuous release and efficient absorption.

Who can participate in this research project?

Researchers interested in joining the project can submit a project proposal via the BioMed X Career Space before October 12, 2025.

Where will the research take place?

The research will be hosted at BioMed X in Heidelberg, Germany.

What are the implications of this research for patients?

Successful development of these technologies could lead to more effective and convenient oral peptide drugs, improving patient compliance and treatment outcomes.

How does this initiative compare to current oral peptide drug delivery methods?

Current methods are limited by low intestinal permeability and rapid gastrointestinal transit; this initiative seeks to overcome these limitations with innovative formulation technologies.

What should researchers know if they are interested in joining the project?

Researchers should prepare a project proposal and submit it via the BioMed X Career Space by the deadline of October 12, 2025.

Who do I contact for more information about this collaboration?

For more information, interested parties can visit the BioMed X website or the Novo Nordisk website, or submit inquiries through the provided project proposal submission link.